These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors. Okada M, Sakamoto T, Yuki T, Mimura T, Nitanda H, Miyoshi K, Tsubota N. J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650 [Abstract] [Full Text] [Related]
9. Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer. Zhong W, Yang X, Bai J, Yang J, Manegold C, Wu Y. Eur J Cardiothorac Surg; 2008 Jul; 34(1):187-95. PubMed ID: 18457958 [Abstract] [Full Text] [Related]
10. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis. Riquet M, Assouad J, Bagan P, Foucault C, Le Pimpec Barthes F, Dujon A, Danel C. Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948 [Abstract] [Full Text] [Related]
11. Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer. Okada M, Sakamoto T, Yuki T, Mimura T, Miyoshi K, Tsubota N. Ann Thorac Surg; 2006 Mar; 81(3):1028-32. PubMed ID: 16488715 [Abstract] [Full Text] [Related]
12. [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer]. Pan TC, Zheng Z, Li J, Chen T, Liu LG, Wei X. Ai Zheng; 2007 Mar; 26(3):303-6. PubMed ID: 17355796 [Abstract] [Full Text] [Related]
13. [Present status and problems of surgical treatment of non-small cell lung cancer]. Fujisawa T, Yamaguchi Y, Shiba M, Baba M, Yusa T, Yamakawa H, Kimura H, Iwai N, Nomoto Y, Yamaguchi T. Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Feb; 28(2):210-5. PubMed ID: 2162440 [Abstract] [Full Text] [Related]
14. [Surgical strategy for stage III non-small cell lung cancer; a review based on our experience and the literature]. Horio H. Gan To Kagaku Ryoho; 2007 Jun; 34(6):836-40. PubMed ID: 17565243 [Abstract] [Full Text] [Related]
16. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer. Misthos P, Sepsas E, Kokotsakis J, Skottis I, Lioulias A. Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761 [Abstract] [Full Text] [Related]
17. Is sampling really effective in staging non-small cell lung cancer? A prospective study. Magnanelli G, Scanagatta P, Benato C, Terzi A, Lonardoni A, Falezza G, Furlan G, Calabrò F. Chir Ital; 2006 Nov; 58(1):19-22. PubMed ID: 16729605 [Abstract] [Full Text] [Related]